Stifel Nicolaus is out with its report today on Nu Skin Enterprises NUS, raising its PT from $43 to $44.
In its report, Stifel Nicolaus writes, "We lift our 2011 and 2012 EPS estimates to $2.47 (was $2.40) and $2.86 (was
$2.79), respectively. We also increase our 12-month price target to $44 per share, 15.4x our new 2012 EPS estimate or 8.0x estimated 2012 EBITDA."
Stifel Nicolaus maintains Buy on NUS.
At the time of posting, shares of NUS were trading at $40.42, down 0.30% from Tuesday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in